{{Rsnum
|rsid=821470
|Gene=NLRC5
|Chromosome=16
|position=57024670
|Orientation=plus
|GMAF=0.4633
|Gene_s=NLRC5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.1 | 48.7 | 6.2
| HCB | 3.6 | 22.6 | 73.7
| JPT | 1.8 | 35.4 | 62.8
| YRI | 57.1 | 36.7 | 6.1
| ASW | 50.9 | 45.6 | 3.5
| CHB | 3.6 | 22.6 | 73.7
| CHD | 4.6 | 30.6 | 64.8
| GIH | 23.8 | 52.5 | 23.8
| LWK | 56.4 | 37.3 | 6.4
| MEX | 24.1 | 46.6 | 29.3
| MKK | 51.9 | 39.7 | 8.3
| TSI | 45.1 | 43.1 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=A
|Pval=0.000003
|OR=1.2500
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}